The objectives of the present study were to (1) investigate the feasibility of the use of the Japanese version of the HVLT-R; (2) identify the clinical factors influencing the HVLT-R (Japanese version) scores of patients who have undergone WBRT; and (3) compare the patients’ NCF after WBRT in different dose fractionation schedules.